SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-22-016910
Filing Date
2022-09-16
Accepted
2022-09-16 08:31:49
Documents
14
Period of Report
2022-09-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K organicellregenra_8k.htm   iXBRL 8-K 41497
2 EXHIBIT 99.1 organicellregenra_ex99-1.htm EX-99.1 14432
  Complete submission text file 0001829126-22-016910.txt   269341

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ocel-20220916.xsd EX-101.SCH 3203
4 XBRL DEFINITION FILE ocel-20220916_def.xml EX-101.DEF 26194
5 XBRL LABEL FILE ocel-20220916_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE ocel-20220916_pre.xml EX-101.PRE 24852
8 EXTRACTED XBRL INSTANCE DOCUMENT organicellregenra_8k_htm.xml XML 4541
Mailing Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 221247013
SIC: 3790 Miscellaneous Transportation Equipment